Renal hemodynamic effects differ between antidiabetic combination strategies: randomized controlled clinical trial comparing empagliflozin/linagliptin with metformin/insulin glargine

Overview of attention for article published in Cardiovascular Diabetology, September 2021

Altmetric Badge

Citations

dimensions_citation: 12 Dimensions

Readers on

mendeley: 57 Mendeley

Summary Dimensions citations

So far, Dimensions has found 12 publications that cite this research output.

12

The most recent citing publications are shown below. View all 12 publications that cite this research output on Dimensions.

SGLT2 inhibitors in peritoneal dialysis: a promising frontier toward improved patient outcomes

Article in Renal Replacement Therapy (January 2024)

Empagliflozin in type 2 diabetes with and without CKD and non-diabetic CKD: Protocol for 3 randomized, double-blind, placebo controlled cross-over trials.

Article in JMIR Research Protocols (January 2024)

Relation between waist circumference and the renal hemodynamic in healthy individuals

Article in Nutrition Metabolism and Cardiovascular Diseases (November 2023)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.